Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 139 results found. Search for [ generic assets ]

Results 80 to 100 of 139
E. Kumar Sharma
July 24, 2015
For instance, in the first quarter of FY16, licensing revenues contributed to Rs 19 crore and the company expects to see this increasing going forward.


PTI
New Delhi, July 23, 2015
The company's net sales rose 15 per cent at Rs 857 crore for the period under review as compared to Rs 742 crore in the year-ago period, Biocon said in a statement.


E. Kumar Sharma
July 16, 2015
Suven has recorded 50 per cent compound annual growth rate (CAGR) since 2011. Its total income were up from Rs 152.25 crore in 2010/11 to Rs 529.8 crore in 2014/15, which is marginally higher than 2013/14.


E Kumar Sharma
May 27, 2015
Mylan is strongly resisting an unsolicited $40 billion bid by Israel-based Teva to acquire Mylan. But on the other hand, it is also pursuing its own $32.7 billion bid to acquire Ireland-based maker of cough and cold remedies.


Reuters
New Delhi, May 22, 2015
The deal also covers the sale by Aspen's Mauritius unit of a portfolio of six branded prescription drugs to Strides' Singapore business.


E. Kumar Sharma
May 21, 2015
A little over three years ago, Strides Arcolab made news by selling its 94 per cent stake in Ascent Pharmahealth, its subsidiary with operations in Australia and Southeast Asia, to Watson Pharmaceuticals (now Actavis Inc) for $393 million.


BT Online Bureau
New Delhi, May 21, 2015
The transaction is expected to close by the end of the second quarter of FY16.


BT Online Bureau
New Delhi, May 21, 2015
Shares of Godrej Properties surged over 6 per cent on Thursday after the company said it sold over 200 apartments, with an area over 400,000 sq ft, in just three weeks after the launch of its new residential project in Gurgaon.


P.B. Jayakumar
May 18, 2015
Industry observers feel it would take a lot of effort for Wockhardt to regain its glory and it won't be easy considering the company's business mix, strategies and product portfolio.


PTI
London, April 28, 2015
Teva had made an offer to acquire all outstanding shares of Mylan at $ 82 per share - 50 per cent in cash and another 50 per cent in stock.


PTI
New Delhi, April 1, 2015
Piramal Enterprises has signed a definitive agreement to sell its clinical research division known as 'Piramal Clinical Research' to Indoco Remedies on a going concern basis for cash, the company said in a filing to BSE.


Lalit K Jha
Washington, January 31, 2015
The merger deal, once consummated, would create India's largest and world's fifth-biggest drug maker.


Ajay Tyagi & Munish Shekhavat
New Delhi, December 26, 2014
The government sought to put controls on drugmakers when it came to pricing of essential drugs, including those for common cough and cold as also for cancer and other diseases.


Rahul Oberoi and Sarbajeet K Sen
December 10, 2014
The financial services sector has emerged as the most favoured since May this year by attracting Rs 11,024 crore till October 15 as against an outflow of Rs 5,666 crore in this period previous year.


Team BT
Delhi, November 10, 2014
The second Business Today-YES Bank Emerging Companies Excellence Survey unearths gems that could go far.


Team BT
October 27, 2014
Featuring news on Facebook, J. Jayalalithaa, Amma brand, Vishal Sikka, Infosys, Amazon, Jeff Bezos, Mark Zuckerberg and more.


Deepak Narayanan
September 22, 2014
The new age CFO must now realise that he is no longer expected to linger in the background and surface every time the results are to be announced.


PTI
New Delhi, August 28, 2014
This is probably the first instance where CCI has ordered a public scrutiny of a proposed merger and acquisition (M&A) deal to ensure compliance to fair trade regulations.


Mail Today Bureau
New Delhi, August 9, 2014
For CCI, this is one of the biggest merger and acquisition deal in the pharma sector and any decision in this case is expected to have wider implications.


PTI
New Delhi, August 8, 2014
The Competition Commission of India would take a final view on the deal after receiving details from them and could seek more information if it is not satisfied with the responses.


PAGES 5 OF 7  12345